Company Profiles

driven by the PitchBook Platform

AudioCure

AudioCure
2010 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$9.7M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer and researcher of treatments for hearing ailments. The company focuses on the clinical development of drugs for diseases related to neurodegeneration.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Biotechnology
Primary Office
  • Schlegelstraße 9
  • 10115 Berlin
  • Germany

+49 030 000000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AudioCure’s full profile, request a free trial.

AudioCure Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 29-Nov-2016 $9.7M 00.00 Completed Generating Revenue
1. Seed Round 29-May-2012 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

AudioCure Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
MED-EL Corporation Minority 000 0000 000000 0
Business Angels Club Berlin-Brandenburg Angel Group Minority 000 0000 000000 0
Federal Ministry for Economic Affairs and Energy Limited Partner Minority 000 0000 000000 0
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0

AudioCure Executive Team (4)

Name Title Board
Seat
Contact
Info
Reimar Schlingensiepen Ph.D Chief Executive Officer
Raik Madla Chief Financial Officer & Chief Technology Officer
Hans Rommelspacher MD CSO & Founder

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »